Jim Callaway
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Jim Callaway
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA.
7
| Subsidiary | Hospital/Nursing Management | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jim Callaway
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | General Counsel | |
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GALECTIN THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| BIOCEPT, INC. | Medical Specialties | Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Ingenuity Systems, Inc.
 Ingenuity Systems, Inc. Information Technology ServicesTechnology Services Ingenuity Systems, Inc. provides intuitive web-based applications for quickly analyzing and accurately interpreting the biological meaning of genomics data. The company was founded in 1998 and is headquartered in Redwood City, CA. | Information Technology Services | Director of Finance/CFO | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Internet Software/Services | Director of Finance/CFO | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sensor Innovations, Inc.
 Sensor Innovations, Inc. BiotechnologyHealth Technology Sensor Innovations, Inc. develops and commercializes a novel, proprietary and versatile sensing technology platform. It is initially focusing on pH measurement in high-value manufacturing, where an internally referenced, continuously self-calibrating sensor without drift is advantageous. The company was founded by Carolyn R. Kahn in 2007 and is headquartered in Burlingame, CA. | Biotechnology | Director/Board Member | |
OrbiMed Israel Partners LP
 OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Investment Managers | Director/Board Member | |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Medical Specialties | Director/Board Member | |
| RENOVORX, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| JCR PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| University of Freiburg | College/University | Doctorate Degree | |
Merrill Lynch Capital Partners, Inc.
 Merrill Lynch Capital Partners, Inc. Investment Banks/BrokersFinance Part of Bank of America Corp., Merrill Lynch Capital Partners, Inc. is a security brokers & dealers. The company is based in New York, NY. The company was founded by Jim J. Burke, Stephen M. McLean. | Investment Banks/Brokers | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| Colorado State University | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree | |
| University of Windsor | College/University | Graduate Degree | |
| University of Portsmouth | College/University | Undergraduate Degree | |
| Universität Stuttgart | College/University | Graduate Degree | |
| Ciba-Geigy Pharmaceuticals | Corporate Officer/Principal | ||
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | General Counsel | |
| LYRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of California | College/University | Doctorate Degree | |
FLG Partners LLC
 FLG Partners LLC Miscellaneous Commercial ServicesCommercial Services FLG Partners LLC is a CFO solutions, CEO, and board advisory services provider based in Silicon Valley. The private company is based in Palo Alto, CA, and has subsidiaries in the United States. The company offers financial and operational leadership to a wide range of companies, from newly funded startups to Fortune 100 companies, across various sectors, including technology, life sciences, and consumer products. The firm's partners engage clients in interim or long-term assignments in leadership roles that typically are consulting engagements. FLG Partners has helped raise over $6 billion in growth financing, IPO, and M&A transactions for the firm's clients since January 2021. The company was founded by Douglas J. Lehrmann, Jeffrey S. Kuhn, Kyle W. Smith. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
New York Pharma Forum, Inc.
 New York Pharma Forum, Inc. Information Technology ServicesTechnology Services New York Pharma Forum, Inc. provides information technology services for the healthcare industry. The private company is based in New York, NY. | Information Technology Services | Director/Board Member | |
Kalgene Pharmaceuticals, Inc.
 Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Kalgene Pharmaceuticals, Inc. develops and focuses on personalized cancer diagnostics and drugs. It offers drugs for epithelial and thyroid cancers. The firm's oncology programs are aimed at improving clinical and survival outcomes through the use of personalized medicine, with a particular focus on bladder, epithelial and thyroid cancers. It serves the biopharmaceutical, research and development and health industries. The company is headquartered in Kingston, Canada. | Medical/Nursing Services | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ALECTOR, INC. | Biotechnology | Director of Finance/CFO | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
| XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member | |
Walden Biosciences, Inc.
 Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Medical/Nursing Services | Chief Executive Officer | |
| APEXIGEN, INC. | Biotechnology | Director of Finance/CFO | |
NURAVAX, INC.
 NURAVAX, INC. Miscellaneous Commercial ServicesCommercial Services The American company specializes in immunotherapy for neurodegenerative disorders. Nuravax aims to create a new segment in the market for the preventive treatment of Alzheimer's disease (AD) and Parkinson's disease (PD) by developing safe and highly immunogenic preventive vaccines for preclinical PD/DLB and AD people based on a set of novel non-invasive and accurate disease biomarkers. The private company estimates the size of this market as approximately 40 million preclinical AD people at risk of disease. Nuravax is licensed for the patented multitep platform technology for the commercialization of prophylactic vaccines against all neurodegenerative disorders. The company is responsible for implementing co-development and sub-licensing agreements with larger biotech and pharmaceutical companies, and for further clinical validation of products. | Miscellaneous Commercial Services | Director/Board Member | |
| Callaway Innovations | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 41 |
| Kanada | 4 |
| Irland | 3 |
| Deutschland | 3 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 10 |
| Finance | 5 |
| Technology Services | 4 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 14 |
| Corporate Officer/Principal | 13 |
| Director of Finance/CFO | 12 |
| Comptroller/Controller/Auditor | 12 |
| Chief Tech/Sci/R&D Officer | 11 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Linda Rubinstein | 16 |
| Steven Schoenfeld | 15 |
| Blaine McKee | 13 |
| Richard Rychlik | 11 |
| James Callaway | 8 |
| Douglas Hunt | 5 |
| Mathias Schmidt | 5 |
- Börse
- Insiders
- Jim Callaway
- Unternehmensverbindungen
